- Home
- Health Tests
- Allergy
- Anaemia
- Andrology
- Autoimmune
- Biochemistry
- Blood Clotting
- Blood Group
- Bone Health
- Bowel Health
- Cancer Related
- Cardiac Health
- Coagulation
- Diabetes
- Fertility
- Genetics
- Haematology
- Health Checks
- Hormones
- Immunity
- Immunology
- Infections
- Inflamations
- Liver Health
- Men's Health
- Microbiology
- Molecular Biology
- Occupational Health
- Pathology
- Pregnancy
- Screen for Drug of Abuse
- Sexual Health
- Thyroid Health
- Vitamins
- Vitamins and Minerals
- Women's Health
- Genetic Tests
- MBMC
- MBMSK
- Aesthetic medicine
- Allergology
- Anatomical Pathology
- Andrology
- Bone Skin And Immune Diseases
- Cardiology
- Cardiovascular
- Custom Panel
- Cytohistology
- Dentistry
- Dermatology
- Endocrinology
- Forensic
- Gastroenterology
- Geriatrics
- Gynecology
- Hematology
- Hepatology
- Immunology
- Infectiology
- Infectivology
- Maxillofacial surgery
- Metabolic diseases
- Miscellaneous
- Neonatology
- Nephrology
- Neurology
- Nutrigenetics
- Nutrition
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology
- Pediatrics
- Pharmacogenetics
- Pneumology
- Prenatal
- Reproduction
- Rheumatology
- Senology
- Sports medicine
- Urology
- PrenatalSAFE® NIPT
- Cancer Screening
- Kits & Supplies
- Services
- About Us
- 0
- £0.000
- Sign in
Description
Craniosynostosis is defined as the premature fusion of one or more cranial sutures leading to secondary distortion of skull shape resulting in skull deformities with a variable presentation. Craniosynostosis may occur in an isolated setting or as part of a syndrome. The incidence of all the craniosynostosis forms is estimated to be between 1/2.000 and 1/2.500 live births. The major part of the syndromic forms (Apert syndrome, Carpenter syndrome, Crouzon syndrome, Muenke syndrome) is caused by mutations in fibroblast transcription factor receptors genes (FGFR). Syndromic forms are inherited in autosomic dominant manner. Mutations in FGFR2 are found to be causative of the Alpert Syndrome.
External Information
Click here for more information about the Apert Syndrome genetic test.Additional information
Samples | EDTA, LA, TB, VC |
---|---|
Method of testing | Sanger/NGS |
Turnaround Time (TAT) | 15 days |
Number of Genes | 1 |
Genes / Chromosomes / SNPs | FGFR2 (exon 4 ) |
External Information | Click here for more information about the Apert Syndrome genetic test. |